National Investment Services’s West Pharmaceutical WST Stock Holding History

National Investment Services’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-4,615	Closed	-$509K	–	82
2019 Q1	$509K	Hold	4,615	–	–	0.56%	60
2018 Q4	$452K	Sell	4,615 -7	-0.2%	-$760	0.52%	62
2018 Q3	$571K	Sell	4,622 -4,239	-48%	-$475K	0.56%	62
2018 Q2	$880K	Buy	8,861 +69	+0.8%	+$6.35K	0.82%	45
2018 Q1	$776K	Buy	8,792 +5,489	+166%	+$513K	0.72%	46
2017 Q4	$326K	Buy	+3,303	New	+$324K	0.31%	64
2017 Q1	–	Sell	-2,394	Closed	-$203K	–	66
2016 Q4	$203K	Buy	+2,394	New	+$188K	0.22%	52
2016 Q3	–	Sell	-3,486	Closed	-$265K	–	61
2016 Q2	$265K	Buy	+3,486	New	+$254K	0.3%	42

Other funds holding WST

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

National Investment Services's WST Position: Q2 2019 in Review

National Investment Services sold out of West Pharmaceutical (WST) in Q2 2019, closing a stake of 4,615 shares — an estimated $509K sold.

National Investment Services first reported a position in WST in Q2 2016 and held it in 8 quarters. The position peaked at $880K in Q2 2018. 374 funds tracked by Wall St. Rank hold WST as of Q2 2019.

National Investment Services reported no remaining West Pharmaceutical position as of Q2 2019 after selling out during the quarter.
National Investment Services sold 4,615 West Pharmaceutical shares in Q2 2019, an estimated $509K.
National Investment Services first reported a position in West Pharmaceutical in Q2 2016 and held it in 8 quarters.
National Investment Services's West Pharmaceutical position peaked at $880K in Q2 2018.
374 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2019.

Based on National Investment Services's 13F filing for Q2 2019, filed 15 Jul 2019.